U.S. Supreme Court Supports Bayer's Request to Limit Roundup Cancer Lawsuits; Stock Rises 20%

The U.S. Supreme Court ruled in support of Bayer's request to restrict state courts from hearing cases related to alleged health injuries from its Roundup herbicide. Following the ruling, Bayer's stock price surged 20%.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments